343 related articles for article (PubMed ID: 28730535)
1. The recomBead Borrelia antibody index, CXCL13 and total IgM index for laboratory diagnosis of Lyme neuroborreliosis in children.
Skogman BH; Lager M; Henningsson AJ; Tjernberg I
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2221-2229. PubMed ID: 28730535
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of two assays for CXCL13 analysis in cerebrospinal fluid for laboratory diagnosis of Lyme neuroborreliosis.
Henningsson AJ; Gyllemark P; Lager M; Skogman BH; Tjernberg I
APMIS; 2016 Nov; 124(11):985-990. PubMed ID: 27651242
[TBL] [Abstract][Full Text] [Related]
3. CXCL13 concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other neurological disorders determined by Luminex and ELISA.
Markowicz M; Schötta AM; Kundi M; Bogovič P; Ogrinc K; Strle F; Stanek G
Ticks Tick Borne Dis; 2018 Jul; 9(5):1137-1142. PubMed ID: 29705691
[TBL] [Abstract][Full Text] [Related]
4. Laboratory diagnosis of Lyme neuroborreliosis: a comparison of three CSF anti-Borrelia antibody assays.
Henningsson AJ; Christiansson M; Tjernberg I; Löfgren S; Matussek A
Eur J Clin Microbiol Infect Dis; 2014 May; 33(5):797-803. PubMed ID: 24263552
[TBL] [Abstract][Full Text] [Related]
5. The B-lymphocyte chemokine CXCL13 in the cerebrospinal fluid of children with Lyme neuroborreliosis: associations with clinical and laboratory variables.
Barstad B; Tveitnes D; Dalen I; Noraas S; Ask IS; Bosse FJ; Øymar K
Infect Dis (Lond); 2019; 51(11-12):856-863. PubMed ID: 31573360
[No Abstract] [Full Text] [Related]
6. The chemokine CXCL13 in cerebrospinal fluid in children with Lyme neuroborreliosis.
Henningsson AJ; Lager M; Brännström R; Tjernberg I; Skogman BH
Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1983-1991. PubMed ID: 30083887
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal Fluid B-lymphocyte Chemoattractant CXCL13 in the Diagnosis of Acute Lyme Neuroborreliosis in Children.
Barstad B; Tveitnes D; Noraas S; Selvik Ask I; Saeed M; Bosse F; Vigemyr G; Huber I; Øymar K
Pediatr Infect Dis J; 2017 Dec; 36(12):e286-e292. PubMed ID: 28661964
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis.
Tjernberg I; Henningsson AJ; Eliasson I; Forsberg P; Ernerudh J
J Infect; 2011 Feb; 62(2):149-58. PubMed ID: 21087629
[TBL] [Abstract][Full Text] [Related]
9. Multiplex assay (Mikrogen recomBead) for detection of serum IgG and IgM antibodies to 13 recombinant antigens of Borrelia burgdorferi sensu lato in patients with neuroborreliosis: the more the better?
Dessau RB; Møller JK; Kolmos B; Henningsson AJ
J Med Microbiol; 2015 Mar; 64(Pt 3):224-231. PubMed ID: 25587083
[TBL] [Abstract][Full Text] [Related]
10. Improvement of diagnostic approach to Lyme neuroborreliosis in children by using recombinant antigens in detection of intrathecally produced IgM/IgG.
Krbková L; Bednářová J; Čermáková Z
Epidemiol Mikrobiol Imunol; 2016; 65(2):112-7. PubMed ID: 27467328
[TBL] [Abstract][Full Text] [Related]
11. Borrelia antibodies in children evaluated for Lyme neuroborreliosis.
Bennet R; Lindgren V; Zweygberg Wirgart B
Infection; 2008 Oct; 36(5):463-6. PubMed ID: 18791841
[TBL] [Abstract][Full Text] [Related]
12. CXCL13 in laboratory diagnosis of Lyme neuroborreliosis-the performance of the recomBead and ReaScan CXCL13 assays in human cerebrospinal fluid samples.
Haglund S; Lager M; Gyllemark P; Andersson G; Ekelund O; Sundqvist M; Henningsson AJ
Eur J Clin Microbiol Infect Dis; 2022 Jan; 41(1):175-179. PubMed ID: 34626256
[TBL] [Abstract][Full Text] [Related]
13. CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.
Ljøstad U; Mygland A
J Neurol; 2008 May; 255(5):732-7. PubMed ID: 18344056
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid chemokine CXCL13 in the diagnosis of neuroborreliosis in children.
Sillanpää H; Skogman BH; Sarvas H; Seppälä IJ; Lahdenne P
Scand J Infect Dis; 2013 Jul; 45(7):526-30. PubMed ID: 23521134
[TBL] [Abstract][Full Text] [Related]
15. Direct Molecular Detection and Genotyping of Borrelia burgdorferi Sensu Lato in Cerebrospinal Fluid of Children with Lyme Neuroborreliosis.
Barstad B; Quarsten H; Tveitnes D; Noraas S; Ask IS; Saeed M; Bosse F; Vigemyr G; Huber I; Øymar K
J Clin Microbiol; 2018 May; 56(5):. PubMed ID: 29467195
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to decorin-binding protein B (DbpB) in the diagnosis of Lyme neuroborreliosis in children.
Sillanpää H; Skogman BH; Sarvas H; Seppälä IJ; Lahdenne P
Int J Infect Dis; 2014 Nov; 28():160-3. PubMed ID: 25316329
[TBL] [Abstract][Full Text] [Related]
17. Application of multiplexing technology to the analysis of the intrathecally released immunoglobulins against B. burgdorferi antigens in neuroborreliosis.
Zajkowska J; Lelental N; Kulakowska A; Mroczko B; Pancewicz S; Bucki R; Kornhuber J; Lewczuk P
Immunol Lett; 2015 Nov; 168(1):58-63. PubMed ID: 26210581
[TBL] [Abstract][Full Text] [Related]
18. Intrathecally produced IgG and IgM antibodies to recombinant VlsE, VlsE peptide, recombinant OspC and whole cell extracts in the diagnosis of Lyme neuroborreliosis.
Stanek G; Lusa L; Ogrinc K; Markowicz M; Strle F
Med Microbiol Immunol; 2014 Apr; 203(2):125-32. PubMed ID: 24363169
[TBL] [Abstract][Full Text] [Related]
19. The Usefulness of Two CXCL13 Assays on Cerebrospinal Fluid for the Diagnosis of Lyme Neuroborreliosis: a Retrospective Study in a Routine Clinical Setting.
van Gorkom T; van Arkel GHJ; Heron M; Voet W; Thijsen SFT; Kremer K
J Clin Microbiol; 2021 Aug; 59(9):e0025521. PubMed ID: 34132584
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid CXCL13 as a diagnostic marker of neuroborreliosis in children: a retrospective case-control study.
Remy MM; Schöbi N; Kottanattu L; Pfister S; Duppenthaler A; Suter-Riniker F
J Neuroinflammation; 2017 Aug; 14(1):173. PubMed ID: 28859668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]